[go: up one dir, main page]

BRPI1006849A2 - composições compreendendo extratos lipofílicos de zingiber officinale e echinacea angustifolia para a prevenção e o tratamento do refluxo gastroesofágico e da êmese induzida por quimioterapia - Google Patents

composições compreendendo extratos lipofílicos de zingiber officinale e echinacea angustifolia para a prevenção e o tratamento do refluxo gastroesofágico e da êmese induzida por quimioterapia

Info

Publication number
BRPI1006849A2
BRPI1006849A2 BRPI1006849A BRPI1006849A BRPI1006849A2 BR PI1006849 A2 BRPI1006849 A2 BR PI1006849A2 BR PI1006849 A BRPI1006849 A BR PI1006849A BR PI1006849 A BRPI1006849 A BR PI1006849A BR PI1006849 A2 BRPI1006849 A2 BR PI1006849A2
Authority
BR
Brazil
Prior art keywords
chemotherapy
prevention
compositions
treatment
gastroesophageal reflux
Prior art date
Application number
BRPI1006849A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41058694&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1006849(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of BRPI1006849A2 publication Critical patent/BRPI1006849A2/pt
Publication of BRPI1006849B1 publication Critical patent/BRPI1006849B1/pt
Publication of BRPI1006849B8 publication Critical patent/BRPI1006849B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1006849A 2009-01-20 2010-01-15 composição compreendendo extratos lipofílicos de zingiber officinale e echinacea angustifolia e seu uso na preparação de um medicamento para prevenção e tratamento de refluxo esofágico BRPI1006849B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2009A000049 2009-01-20
IT000049A ITMI20090049A1 (it) 2009-01-20 2009-01-20 Composizioni a base di estratti lipofili di zingiber officinale e di echinacea angustifolia per la prevenzione e il trattamento del riflusso gastro-esofageo e dell'emesi indotta da chemioterapici
PCT/EP2010/000204 WO2010083967A1 (en) 2009-01-20 2010-01-15 Compositions comprising lipophilic extracts of zingiber officinale and echinacea angustifolia for the prevention and treatment of gastro-oesophageal reflux and chemotherapy-induced emesis

Publications (3)

Publication Number Publication Date
BRPI1006849A2 true BRPI1006849A2 (pt) 2016-03-15
BRPI1006849B1 BRPI1006849B1 (pt) 2021-04-06
BRPI1006849B8 BRPI1006849B8 (pt) 2021-05-25

Family

ID=41058694

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006849A BRPI1006849B8 (pt) 2009-01-20 2010-01-15 composição compreendendo extratos lipofílicos de zingiber officinale e echinacea angustifolia e seu uso na preparação de um medicamento para prevenção e tratamento de refluxo esofágico

Country Status (21)

Country Link
US (2) US8361521B2 (pt)
EP (1) EP2379095B1 (pt)
JP (1) JP2012515715A (pt)
KR (1) KR101740491B1 (pt)
CN (1) CN102281889A (pt)
AU (1) AU2010206326B2 (pt)
BR (1) BRPI1006849B8 (pt)
CA (1) CA2750025C (pt)
CL (1) CL2011001751A1 (pt)
DK (1) DK2379095T3 (pt)
ES (1) ES2429018T3 (pt)
HR (1) HRP20130977T1 (pt)
IL (1) IL214161A (pt)
IT (1) ITMI20090049A1 (pt)
MX (1) MX2011007685A (pt)
PL (1) PL2379095T3 (pt)
PT (1) PT2379095E (pt)
RU (1) RU2524625C2 (pt)
SG (1) SG173054A1 (pt)
SI (1) SI2379095T1 (pt)
WO (1) WO2010083967A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401141B1 (it) 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico
ITMI20121317A1 (it) * 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
JP6198427B2 (ja) * 2013-03-29 2017-09-20 小林製薬株式会社 ゼラチン類を含有する経口組成物
ITMI20130807A1 (it) 2013-05-16 2014-11-17 Indena Spa Combinazioni di estratti di serenoa repens e di estratti lipofili di zingiber officinalis e di echinacea angustifolia, loro uso e formulazioni che li contengono
KR101549746B1 (ko) * 2013-08-22 2015-09-04 충북대학교 산학협력단 생강의 용매분획을 유효성분으로 포함하는 기능성 위장장애 및 위장관 운동장애의 예방 및 치료용 약학적 조성물
KR101868225B1 (ko) 2016-09-22 2018-06-15 주식회사 담터 생강으로부터 쇼가올을 추출하는 방법
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
IT202000003092A1 (it) * 2020-02-17 2021-08-17 Neilos S R L Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0464298B1 (en) * 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
US5744187A (en) * 1996-12-16 1998-04-28 Gaynor; Mitchel L. Nutritional powder composition
WO1999021007A1 (en) * 1997-10-23 1999-04-29 Pharmaprint, Inc. Pharmaceutical grade echinacea
DE19859499C2 (de) * 1998-12-22 2002-10-24 Schwabe Willmar Gmbh & Co Stabile Ingwerextraktzubereitung
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
TWI290469B (en) * 2000-07-12 2007-12-01 Medical & Pharm Ind Tech & Dev Method for manufacturing product with component capable of efficiently preventing inflammation and platelets agglutination form ginger and medical composition with the efficient component
US6274177B1 (en) * 2000-08-26 2001-08-14 National Science Council Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract
US7037524B2 (en) * 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
WO2008070783A2 (en) * 2006-12-07 2008-06-12 Herbalscience Singapore Pte. Ltd. Compositions and methods comprising zingiber species

Also Published As

Publication number Publication date
US20130108720A1 (en) 2013-05-02
AU2010206326B2 (en) 2014-04-24
EP2379095B1 (en) 2013-07-31
HRP20130977T1 (hr) 2013-11-22
ITMI20090049A1 (it) 2010-07-21
KR20110107339A (ko) 2011-09-30
BRPI1006849B1 (pt) 2021-04-06
CA2750025C (en) 2017-07-11
JP2012515715A (ja) 2012-07-12
MX2011007685A (es) 2011-08-12
ES2429018T3 (es) 2013-11-12
WO2010083967A1 (en) 2010-07-29
PL2379095T3 (pl) 2013-12-31
SG173054A1 (en) 2011-08-29
RU2524625C2 (ru) 2014-07-27
AU2010206326A1 (en) 2011-08-11
CA2750025A1 (en) 2010-07-29
DK2379095T3 (da) 2013-09-08
BRPI1006849B8 (pt) 2021-05-25
KR101740491B1 (ko) 2017-05-26
IL214161A (en) 2015-08-31
US20120040031A1 (en) 2012-02-16
US8859019B2 (en) 2014-10-14
PT2379095E (pt) 2013-10-02
CN102281889A (zh) 2011-12-14
CL2011001751A1 (es) 2011-11-11
EP2379095A1 (en) 2011-10-26
RU2011129984A (ru) 2013-02-27
IL214161A0 (en) 2011-08-31
US8361521B2 (en) 2013-01-29
SI2379095T1 (sl) 2013-10-30

Similar Documents

Publication Publication Date Title
BRPI1006849A2 (pt) composições compreendendo extratos lipofílicos de zingiber officinale e echinacea angustifolia para a prevenção e o tratamento do refluxo gastroesofágico e da êmese induzida por quimioterapia
DK2598156T3 (da) Formuleringer, indeholdende ekstrakter af echinacea angustifolia og zingiber officinale, som er anvendelige ved reduktion af inflammation og perifer smerte
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BRPI0820528A2 (pt) formulação de revestimento entérica dispersável em água para formas de dosagem nutracêuticas e farmacêuticas
BRPI0923171A2 (pt) Prevenção e tratamento da diarréia causada por rotavírus.
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI1006915A2 (pt) composições compreendendo um extrato lipofílico de zingiber officinale e um extrato de cynara scolymus que são úteis para a prevenção e tratamento do refluxo esofágico e da síndrome do cólon irritável.
BRPI0815353A2 (pt) Compoições e dhea para o tratamento da menopausa
BRPI0810240A2 (pt) Métodos e composições para selecionar plantas de soja resistentes à podridão de raiz por phytophthora
ATE542815T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
ES2398124T8 (es) Procedimiento y dispositivos para la modificación de sesión de terceros
BRPI1010125A2 (pt) Uso de uma mistura, mistura para o aumento da saúde de uma planta e composição pesticida para o aumento da saúde de uma planta
BRPI0822572A2 (pt) Terapia guiada por imagem de doença moicardial, composição manufaturamento e aplicações
PT2186889E (pt) Péptido cdca1 e agente farmacêutico que o compreende
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
BRPI0918876A2 (pt) composições para a profilaxia e tratamento de doença dermatológica/mucosa, e suas utilizações
BRPI0811870A2 (pt) Tratamento e prevenção de influenza
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI0722183A2 (pt) Composições farmacêuticas para tratar depressão e ansiedade
BRPI0820490A2 (pt) extrato de sementes de fraxinus excelsior e aplicações terapêuticas para o mesmo.
BR112012000383A2 (pt) composições farmacêuticas e formas sólidas
BRPI0812028A2 (pt) extrato de planta e seu uso terapêutico
EP2341047A4 (en) CYCLOHEXANE DERIVATIVE AND ITS PHARMACEUTICAL USE
BRPI0912736A2 (pt) extrato de planta e seu uso terapêutico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2475 DE 12/06/2018 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/01/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2757 DE 07-11-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.